1. Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified
    Takahiro Ota et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
  2. Molecular Pathology of Non–Small Cell Lung Cancer
    Dara L. Aisner et al, 2012, American Journal of Clinical Pathology CrossRef
  3. Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma
    Young Wha Koh et al, 2016, Oncology CrossRef
  4. Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: a systematic review and meta-analysis of clinical characteristics
    Wenjie Liu et al, 2023, BMC Cancer CrossRef
  5. Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective
    Elisa Brega et al, 2014, Frontiers in Oncology CrossRef
  6. Squamous cell lung carcinoma with gastrointestinal metastasis: a case report and review of literature
    Feifei Li et al, 2023, Frontiers in Oncology CrossRef

  7. A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity


    Chung-Shien Lee et al, 2020, Lung Cancer: Targets and Therapy CrossRef
  8. EGFRmutation identifies distant squamous cell carcinoma as metastasis from lung adenocarcinoma
    Nobuhiro Kanaji, 2013, World Journal of Respirology CrossRef
  9. Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis
    Haiyan Wang et al, 2021, Computational and Mathematical Methods in Medicine CrossRef